导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 23.99% | 165/1050 |
| 近一周 | -1.81% | 396/1104 |
| 近一月 | -4.61% | 593/1102 |
| 近一季 | 1.61% | 233/1092 |
| 近半年 | 21.95% | 122/1070 |
| 近一年 | 29.71% | 159/1018 |
| 近两年 | 87.81% | 240/926 |
| 近三年 | 42.31% | 313/833 |
| 成立以来 | 354.78% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.32% 461/1070 |
40.20% 259/1101 |
- - |
- - |
| 2025 | 27.06% 536/1065 |
3.74% 498/1014 |
-2.83% 882/1038 |
32.54% 327/1050 |
-4.89% 703/1065 |
| 2024 | 1.68% 533/1011 |
-2.45% 444/960 |
-4.65% 617/983 |
16.33% 162/991 |
-6.02% 734/1011 |
| 2023 | -17.15% 602/952 |
-1.29% 681/880 |
-6.62% 616/895 |
0.68% 67/915 |
-10.72% 878/952 |
| 2022 | -17.72% 245/867 |
-8.76% 82/773 |
7.36% 383/806 |
-15.68% 603/845 |
-0.38% 461/867 |
| 2021 | 4.72% 304/740 |
-0.27% 162/580 |
7.92% 411/659 |
-9.12% 483/704 |
7.06% 144/740 |
| 2020 | 53.05% 226/554 |
-5.33% 300/419 |
22.73% 229/466 |
11.90% 204/517 |
17.72% 160/554 |
| 2019 | 41.85% 206/410 |
24.08% 777/1149 |
-0.22% 376/1231 |
-2.10% 361/390 |
17.02% 32/410 |
| 2018 | -23.57% 126/349 |
- - |
- - |
- - |
-9.63% 267/1080 |
| 2017 | 38.60% 17/285 |
- - |
- - |
- - |
- - |
| 2016 | 8.49% 7/205 |
- - |
- - |
- - |
- - |
| 2015 | 48.40% 25/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 安信价值精选股票 VS. 东吴新产业精选股票A(580008) |